Insider · CIK 0001332764

Dunsire Deborah

Reports to the SEC for 6 companies · IRVING, TX

sec.gov

Transactions

Companies

Filings

CIK

0001332764

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-22	MCKMCKESSON CORP · Restricted Stock Units (RSUs)A Award	Director	AAward	+277 sh	—	—	277
2026-05-14	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+7,751 sh	—	—	38,566
2026-05-14	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.1K sh	—	—	14,058
2025-07-30	MCKMCKESSON CORP · Restricted Stock Units (RSUs)A Award	Director	AAward	+301 sh	—	—	301
2025-05-15	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+5,740 sh	—	—	30,815
2025-05-15	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10.8K sh	—	—	10,787
2024-07-31	MCKMCKESSON CORP · Restricted Stock Units (RSUs)A Award	Director	AAward	+349 sh	—	—	349
2024-06-18	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+5,345 sh	—	—	25,075
2024-06-18	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,900 sh	—	—	9,900
2024-06-05	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2024-06-05	Syros Pharmaceuticals, Inc.Restricted Stock UnitsA Award	Director	AAward	+4,000 sh	—	—	4,000
2024-06-03	MCKMCKESSON CORP · Restricted Stock Units (RSUs)A Award	Director	AAward	+56 sh	—	—	56
2024-06-01	Syros Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,000 sh	—	—	0
2024-06-01	Syros Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	—	—	12,000
2023-06-07	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,110 sh	—	—	7,110
2023-06-07	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+3,860 sh	—	—	19,730
2023-06-01	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2023-06-01	Syros Pharmaceuticals, Inc.Restricted Stock UnitsA Award	Director	AAward	+4,000 sh	—	—	4,000
2022-09-16	Syros Pharmaceuticals, Inc.A Award	Director	AAward	+8,000 sh	—	—	8,000
2022-09-16	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2022-06-24	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,245 sh	—	—	6,245
2022-06-24	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+3,300 sh	—	—	15,870
2022-06-01	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2021-09-09	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2021-07-21	ALEXION PHARMACEUTICALS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−14.6K sh	—	—	0
2021-06-24	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+2,145 sh	—	—	12,570
2021-06-24	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+4,125 sh	—	—	4,125
2021-05-20	ALEXION PHARMACEUTICALS, INC.A Award	Director	AAward	+533 sh	—	—	14,629
2021-05-20	ALEXION PHARMACEUTICALS, INC.A Award	Director	AAward	+1,962 sh	—	—	14,096
2020-06-26	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+2,550 sh	—	—	10,425
2020-06-26	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+4,250 sh	—	—	4,250
2020-05-14	ALEXION PHARMACEUTICALS, INC.A Award	Director	AAward	+941 sh	—	—	12,134
2020-05-14	ALEXION PHARMACEUTICALS, INC.A Award	Director	AAward	+3,468 sh	—	—	11,193
2019-06-11	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+3,000 sh	—	—	7,875
2019-06-11	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2019-05-15	ALEXION PHARMACEUTICALS, INC.A Award	Director	AAward	+2,726 sh	—	—	6,985
2019-05-15	ALEXION PHARMACEUTICALS, INC.A Award	Director	AAward	+740 sh	—	—	7,725
2018-06-19	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2018-06-19	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+3,000 sh	—	—	4,875
2018-05-09	ALEXION PHARMACEUTICALS, INC.A Award	Director	AAward	+2,174 sh	—	—	4,259
2018-02-08	ALEXION PHARMACEUTICALS, INC.A Award	Director	AAward	+2,085 sh	—	—	2,085
2017-06-22	RAREUltragenyx Pharmaceutical Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+3,750 sh	—	—	3,750
2017-06-22	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+1,875 sh	—	—	1,875
2017-04-06	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2015-03-17	ALLERGAN INCPhantom Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−8,859.73 sh	—	—	0
2015-03-17	ALLERGAN INCM Exercise/Conversion	Director	MExercise/Conversion	+8,859.73 sh	—	—	43,040.73
2015-03-17	ALLERGAN INCNonemployee Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11.4K sh	—	—	0
2015-03-17	ALLERGAN INCNonemployee Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11.4K sh	—	—	0
2015-03-17	ALLERGAN INCD Disposition to Issuer	Director	DDisposition to Issuer	−43K sh	—	—	0
2015-03-17	ALLERGAN INCNonemployee Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11.4K sh	—	—	0

Recent filings

Accepted (ET)
Jul 234
Dunsire Deborah0000927653-26-000200
SEC(opens sec.gov)
May 184
Dunsire Deborah0001193125-26-229222
SEC(opens sec.gov)
Jul 314
Dunsire Deborah0000927653-25-000088
SEC(opens sec.gov)
May 194
Dunsire Deborah0000950170-25-074662
SEC(opens sec.gov)
Aug 14
Dunsire Deborah0001062993-24-014315
SEC(opens sec.gov)
Jun 204
Dunsire Deborah0000950170-24-075491
SEC(opens sec.gov)
Jun 74
Dunsire Deborah0000950170-24-070704
SEC(opens sec.gov)
Jun 44
Dunsire Deborah0000950170-24-068759
SEC(opens sec.gov)
Jun 44
Dunsire Deborah0001062993-24-011837
SEC(opens sec.gov)
Jun 94
Dunsire Deborah0001209191-23-035687
SEC(opens sec.gov)
Jun 24
Dunsire Deborah0001209191-23-033718
SEC(opens sec.gov)
Sep 194
Dunsire Deborah0001209191-22-050550
SEC(opens sec.gov)

Companies

Address

6555 NORTH STATE HWY 161

IRVING, TX, 75039